Polarityte Stock Forecast, Price & News

Polarityte's stock was trading at $1.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PTE shares have decreased by 2.8% and is now trading at $1.04.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Polarityte.

Polarityte is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Polarityte.

Polarityte Inc (NASDAQ:PTE) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($0.33) EPS for the quarter, beating the Zacks' consensus estimate of ($0.40) by $0.07. The firm had revenue of $2.27 million for the quarter, compared to analysts' expectations of $0.85 million. Polarityte had a negative net margin of 1,152.56% and a negative return on equity of 179.96%. During the same period in the prior year, the business posted ($0.92) earnings per share.
View Polarityte's earnings history.

Polarityte issued an update on its third quarter 2020 Pre-Market earnings guidance on Monday, September, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.2 million, compared to the consensus revenue estimate of $2.85 million.

5 analysts have issued 12-month price objectives for Polarityte's stock. Their forecasts range from $3.00 to $6.00. On average, they expect Polarityte's stock price to reach $4.40 in the next year. This suggests a possible upside of 323.1% from the stock's current price.
View analysts' price targets for Polarityte.

Polarityte saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 2,550,000 shares, a decline of 9.6% from the August 31st total of 2,820,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 10.7% of the shares of the company are sold short.
View Polarityte's Short Interest.

Some companies that are related to Polarityte include GENFIT S A/ADR (GNFT), INmune Bio (INMB), Fennec Pharmaceuticals (FENC), Lineage Cell Therapeutics (LCTX), Cidara Therapeutics (CDTX), Applied Genetic Technologies (AGTC), TrovaGene (TROV), Champions Oncology (CSBR), Windtree Therapeutics (WINT), La Jolla Pharmaceutical (LJPC), Erytech Pharma (ERYP), Gritstone Oncology (GRTS), Gamida Cell (GMDA), Verona Pharma (TARA) and X4 Pharmaceuticals (XFOR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Polarityte investors own include BioNano Genomics (BNGO), Gran Tierra Energy (GTE), Pennsylvania R.E.I.T. (PEI), Matinas BioPharma (MTNB), Cannabics Pharmaceuticals (CNBX), Novan (NOVN), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), OrganiGram (OGI) and AEterna Zentaris (AEZS).

Polarityte trades on the NASDAQ under the ticker symbol "PTE."

Polarityte's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (1.95%), FMR LLC (1.95%), Advisor Group Holdings Inc. (0.46%), Jane Street Group LLC (0.24%), Bernardo Wealth Planning LLC (0.21%) and Levin Capital Strategies L.P. (0.10%). Company insiders that own Polarityte stock include Cameron J Hoyler, David B Seaburg, Denver Lough, Edward Winslow Swanson, Jeffrey Hansen Dyer, Paul Elliot Mann, Peter A Cohen, Rainer M Erdtmann, Richard Hague and Steve Gorlin.
View institutional ownership trends for Polarityte.

PTE stock was sold by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., FMR LLC, FMR LLC, and Advisor Group Holdings Inc.. Company insiders that have sold Polarityte company stock in the last year include Cameron J Hoyler, David B Seaburg, Denver Lough, Jeffrey Hansen Dyer, Paul Elliot Mann, Rainer M Erdtmann, and Richard Hague.
View insider buying and selling activity for Polarityte.

PTE stock was bought by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Verition Fund Management LLC, and Bernardo Wealth Planning LLC. Company insiders that have bought Polarityte stock in the last two years include Edward Winslow Swanson, Paul Elliot Mann, and Peter A Cohen.
View insider buying and selling activity for Polarityte.

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PTE stock can currently be purchased for approximately $1.04.

Polarityte has a market capitalization of $40.29 million and generates $5.65 million in revenue each year. The company earns $-92,490,000.00 in net income (profit) each year or ($3.70) on an earnings per share basis. Polarityte employs 153 workers across the globe.

The official website for Polarityte is www.polarityte.com.

Polarityte's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]